Art

J-GLOBAL ID：201802238230188625   Reference number：18A0319140

Predominance of Serogroup 19 CC320/271 among Penicillin-Nonsusceptible Streptococcus pneumoniae Isolates after Introduction of the PCV7 Vaccine in Several Regions of Japan

日本における数地域におけるPCV7ワクチン導入後に分離されたペニシリン非感受性肺炎球菌における血清型19 CC320/271の有意性

Author (9)： Oodate Mitsuru (Department of Bacteriology, Nagoya University Graduate School of Medicine) ,  Oodate Mitsuru (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine) ,  Kimura Kouji (Department of Bacteriology, Nagoya University Graduate School of Medicine) ,  Banno Hirotsugu (Department of Bacteriology, Nagoya University Graduate School of Medicine) ,  Yokoyama Satoru (Department of Bacteriology, Nagoya University Graduate School of Medicine) ,  Jin Wanchun (Department of Bacteriology, Nagoya University Graduate School of Medicine) ,  Wachino Jun-ichi (Department of Bacteriology, Nagoya University Graduate School of Medicine) ,  Hasegawa Yoshinori (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine) ,  Arakawa Yoshichika (Department of Bacteriology, Nagoya University Graduate School of Medicine)
Material： Japanese Journal of Infectious Diseases  (日本感染症雑誌)
Volume： 71  Issue： 1  Page： 14-20(J-STAGE)  Publication year： 2018 
JST Material Number： F0552A  ISSN： 1344-6304  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *PCV7 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0319140&from=J-GLOBAL&jstjournalNo=F0552A") }}

Author keywords (5)： Streptococcus pneumoniae ,  penicillin non-susceptible ,  multilocus sequence typing ,  penicillin-binding protein genes ,  CC320/271

JST classification (2)： Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O)

Substance index (2)： Cefotaxime ,  Meropenem

Reference (32)：

• 1. Ball P. Therapy for pneumococcal infection at the millennium: doubts and certainties. Am J Med. 1999;107:77S-85S.
• 2. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77-83.
• 3. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-46.
• 4. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005;54:893-7.
• 5. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-27.

Terms in the title (8)： 日本 ,  地域 ,  PCV7 ,  ワクチン ,  ペニシリン ,  感受性 ,  肺炎球菌 ,  血清型